Target Audience

Family physicians, cardiovascular specialists and allied health professionals.

View Agenda

Program Access

Program Description

This program provides a case-based discussion on SGLT2 inhibition for glycemic control and newer indications such as heart failure prevention, treatment, and management of chronic kidney disease.

Credit

This program is NOT accredited.

Mainpro+ participants may earn certified credits by completing a Linking Learning Exercise.

Specialist participants may claim Section 2 credits (up to 2 credits per hour) following completion of a personal learning project (PLP) under Section 2: Self-Learning Activities within the MAINPORT ePortfolio.